HomeCo-Payment FundingsHomeCo-Payment FundingsAll Co-Payment FundingsWe don't have any resources for the co-payment funding "Anal Cancer".Disease StateStatusInsurance TypeFPL % Acute Lymphoblastic LeukemiaOpenFederal/Medicare500Acute Myeloid LeukemiaClosedFederal/Medicare500Bladder CancerClosedFederal/Medicare500Bone MetastasesClosedFederal/Medicare500Breast CancerClosedANY500Cancer-Related Pain ManagementClosedFederal/Medicare500Cervical CancerOpenANY500Chemotherapy Induced NeutropeniaClosedFederal/Medicare500Cholangiocarcinoma (Bile Duct Cancer)OpenFederal/Medicare500Chronic Lymphocytic LeukemiaOpenFederal/Medicare500Chronic Myeloid LeukemiaClosedFederal/Medicare500Gastric CancerOpenANY500Gastrointestinal Stromal TumorsClosedFederal/Medicare500GlioblastomaClosedANY500Head and Neck CancerClosedANY500Hepatocellular Carcinoma (HCC)OpenFederal/Medicare500Malignant MesotheliomaClosedFederal/Medicare500MelanomaClosedFederal/Medicare500Merkel Cell CarcinomaClosedFederal/Medicare500Metastatic Breast CancerClosedFederal/Medicare500Metastatic Colorectal CancerClosedFederal/Medicare500Metastatic Differentiated Thyroid CancerClosedFederal/Medicare500Metastatic Pheochromocytoma and ParagangliomaClosedFederal/Medicare500Metastatic Prostate CancerClosedFederal/Medicare500Metastatic Skin Cancer - Non MelanomaClosedFederal/Medicare500Multiple MyelomaClosedFederal/Medicare500Myeloproliferative NeoplasmsOpenFederal/Medicare500Non-Hodgkin LymphomaClosedFederal/Medicare500Non-Small Cell Lung CancerClosedFederal/Medicare500Ovarian CancerClosedFederal/Medicare500Pancreatic CancerOpenANY500Pancreatic Neuroendocrine Tumor (PNET)ClosedANY500Prostate CancerClosedFederal/Medicare500Renal Cell CancerOpenFederal/Medicare500Small Cell Lung CancerOpenFederal/Medicare500Soft Tissue SarcomaClosedANY500Uterine/Endometrial CancerClosedFederal/Medicare500
